Ignite Planners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Ignite Planners's XBI Position: Q1 2026 in Review
Ignite Planners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.64% in Q1 2026, buying an estimated $1.87K and bringing the position to 2,362 shares worth $302K. The position accounts for 0.05% of the portfolio, ranked #321.
Ignite Planners first reported a position in XBI in Q1 2024 and has held it in 4 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Ignite Planners held 2,362 shares of State Street SPDR S&P Biotech ETF worth $302K as of Q1 2026.
- Ignite Planners bought 15 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.87K.
- State Street SPDR S&P Biotech ETF made up 0.05% of Ignite Planners's portfolio in Q1 2026, its #321 holding.
- Ignite Planners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 4 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Ignite Planners's 13F filing for Q1 2026, filed 17 Apr 2026.